EFFECT OF EBV AND HHV-6 LATENT INFECTION OR REACTIVATION ON MS ACTIVITY: A PROSPECTIVE CLINICAL COHORT STUDY

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Multiple Sclerosis (MS) is a severely debilitating neurodegenerative disease, affecting over 16,000 Australians. There is a need to examine which factors drive the progression of this disease. We examine the role of two viral infections on MS activity. It has the potential to contribute to antiviral interventions that might prevent relapses and-or decrease the clinical progression of this debilitating disease.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2008

Funding Scheme: NHMRC Project Grants

Funding Amount: $263,845.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Optical technology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Disease progression | Epidemiology | Multiple Sclerosis | Prospective cohort | Relapse | Virus pathogenesis